Additional file 1: Table S1. of A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma

Prognostic factors for overall survival (Univariate) (N = 104). Table S2. Prognostic factors for overall survival (multivariable) (N = 104). Table S3. Toxicities in stage III and IV patients with h-R3/RT and CDDP/RT (N = 78). Table S4. Assignment expressions for factors in the table of patients’ characteristics. Table S5. Patients’ compliance (104 cases). Table S6. Neoadjuvant chemotherapy was recommended by NCCN guidelines of Head and Neck Cancer. Table S7. General information for all 302 patients of CDDP/RT and h-R3/RT group. Table S8. Prognostic factors for Overall Survival of all 302 patients (Univariate). Table S9. Prognostic factors for Overall Survival of all 302 patients (Multivariable). (ZIP 437 kb

Additional file 2: Figure S1. of A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma

Overall survival of stage II patients who received h-R3/RT or CDDP/RT. Figure S2. Overall survival of patients aged more than 60 years old who received h-R3/RT or CDDP/RT. Figure S3. Overall survival in stage III and IV patients with h-R3/RT and CDDP/RT. (ZIP 12 kb